Life Sciences Nova Scotia
  • About
    • Who We Are
    • What we do
    • Why work in Nova Scotia?
    • Contact us
  • Members
    • Member Directory
    • Member Benefits
    • Become a member
  • Resources
    • Member Programs
    • News and success stories
    • Member Job Board
  • Events
    • Events
    • BioPort Atlantic
    • Atlantic Precision Medicine Conference
  • Podcast
Select Page
Bioteem40 Selected as Finalist for INMC Pitch Competition

Bioteem40 Selected as Finalist for INMC Pitch Competition

by Life Sciences Nova Scotia | Apr 22, 2026 | Success Story

We are pleased to recognize our member Bioteem40, who were selected to represent Kings County in the International Network of Michelin Cities Startup Pitch Competition. Based in Windsor, Bioteem40 creates simple, all in one nutrition products designed to support...
Sona Nanotech’s Cancer Therapy Shows Potential in New Study

Sona Nanotech’s Cancer Therapy Shows Potential in New Study

by Life Sciences Nova Scotia | Apr 13, 2026 | Success Story

From: Sona Nanotech Inc. Date: April 7, 2026 Sona Nanotech Inc. (CSE: SONA, OTCQB: SNANF) (the “Company”, “Sona”) is excited to announce publication of a preclinical study using its Targeted Hyperthermia Therapy (“THT”) to treat cancer, in the Journal of...
Twelve Start-ups Selected for First Cohort of 2026-2027 Accelerate

Twelve Start-ups Selected for First Cohort of 2026-2027 Accelerate

by Life Sciences Nova Scotia | Mar 23, 2026 | News

From: Invest Nova ScotiaDate: Mar.18, 2026 Join us in congratulating the start-ups selected to participate in the first cohort of Invest Nova Scotia Accelerate 2026–2027. This year, companies were accepted into one of two newly launched streams, the Growth Stream and...
Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

by Life Sciences Nova Scotia | Mar 13, 2026 | News

From: Agilent Technologies Inc.Date: Mar.11, 2026 Agilent Technologies Inc. today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company’s expanding capabilities...
ABK Biomedical Closed $35M Financing Round in 2025

ABK Biomedical Closed $35M Financing Round in 2025

by Life Sciences Nova Scotia | Feb 20, 2026 | News

From: EntrevestorDate: Feb.18, 2026 ABK Biomedical late last year raised US$35 million (C$47.9 million) in a Series D financing round to support clinical trials, manufacturing expansion and development of a product to be used in treating liver cancer. The...
« Older Entries

Recent Posts

  • Bioteem40 Selected as Finalist for INMC Pitch Competition
  • Sona Nanotech’s Cancer Therapy Shows Potential in New Study
  • Twelve Start-ups Selected for First Cohort of 2026-2027 Accelerate
  • Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States
  • ABK Biomedical Closed $35M Financing Round in 2025
No comments to show.
[buddybot_chat id=1]

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow